James F. Reddoch, EVP, Research & Investments at Royalty Pharma plc (RPRX), sold 111,428 shares at $42.10 ($4.7M) on 2021-04-14, disclosed to the SEC on 2021-04-16.
Open-market sale of $4.7M RPRX by EVP, Research & Investments. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.10 | 55,714 | $2.3M | 50.0% |
| 2 | $42.10 | 55,714 | $2.3M | 50.0% |
| Total | $42.10 avg | 111,428 | $4.7M | 100% |
| Filing → |
| RPRX | SELL | 2022-05-31 | $3.1M | — | Filing → |
| RPRX | SELL | 2022-05-23 | $3.0M | — | Filing → |
| RPRX | SELL | 2021-07-27 | $712K | — | Filing → |